Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Celgene Corp. for $13.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

This company was transferred to the archive: financial data is no longer updated!

Microsoft Excel LibreOffice Calc

Celgene Corp. (CELG)

Cash Flow Statement

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Celgene Corp., consolidated cash flow statement

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net income
Depreciation
Amortization
Impairment charges
Deferred income taxes
Change in value of contingent consideration and success payments
Gain on sale of business
Net (gain) loss on sales of debt securities available-for-sale and equity investments
Fair value adjustments on equity investments
Share-based compensation expense
Share-based employee benefit plan expense
Derivative instruments
Other, net
Accounts receivable
Inventory
Other operating assets
Accounts payable and other operating liabilities
Income tax payable
Payment of contingent consideration
Deferred revenue
Change in current assets and liabilities, excluding the effect of acquisitions
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Proceeds from sales of debt securities available-for-sale
Purchases of debt securities available-for-sale
Capital expenditures
Proceeds from sales of equity investment securities
Purchases of equity investment securities
Payments for acquisition of businesses, net of cash acquired
Other investing activities
Net cash used in investing activities
Payment for treasury shares
Proceeds from short-term borrowing
Principal repayments on short-term borrowing
Proceeds from the issuance of long-term debt
Repayments of long-term debt
Net proceeds (payments) from common equity put options
Payment of contingent consideration
Net proceeds from share-based compensation arrangements
Excess tax benefit from share-based compensation arrangements
Net cash provided by (used in) financing activities
Effect of currency rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Celgene Corp.’s net cash provided by operating activities increased from 2016 to 2017 but then slightly decreased from 2017 to 2018.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Celgene Corp.’s net cash used in investing activities decreased from 2016 to 2017 and from 2017 to 2018.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Celgene Corp.’s net cash provided by (used in) financing activities increased from 2016 to 2017 and from 2017 to 2018.